Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<ul><li>Heaton’s journey to Zomedica. Heaton mapped his journey to animal health and Zomedica.</li><li>Having started in human health with surgical device company US Surgical Corporation (USCC), where he gained experience in selling innovative solutions to surgeons, and then after leading several start-ups in a few different areas of healthcare, he was appointed CEO of Zomedica in October 2021.</li><li>The opportunity to lead the animal healthcare company appealed to Heaton both from the standpoint of being able to help pets and also because of the relative freedom that animal healthcare afforded to innovate and get to market from a regulatory standpoint compared with the human side of healthcare.</li></ul>

Heaton’s journey to Zomedica. Heaton mapped his journey to animal health and Zomedica.Having started in human health with surgical device company US Surgical Corporation (USCC), where he gained experience in selling innovative solutions to surgeons, and then after leading several start-ups in a few different areas of healthcare, he was appointed CEO of Zomedica in October 2021.The opportunity to lead the animal healthcare company appealed to Heaton both from the standpoint of being able to help pets and also because of the relative freedom that animal healthcare afforded to innovate and get to market from a regulatory standpoint compared with the human side of healthcare.

WTR Biotech Spotlight Podcast Recap Zomedica Corp. (ZOMDF)

United States

Zomedica Corp. operates as a veterinary biopharmaceutical company. The Company focuses on the needs of the veterinarians by offering drug discovery and development for pet health. Zomedica serves customers in North America.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zomedica (ZOM US)

WTR Biotech Spotlight Podcast Recap Zomedica Corp. (ZOMDF)

Under Heaton’s tenure, Zomedica has expanded its suite of offerings from one product to six. All are proprietary, highly differentiated, either...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)